Organon Pharma Indonesia Tbk PT - ESG Rating & Company Profile powered by AI
The ESG assessment for Organon Pharma Indonesia Tbk PT indicates its transparency towards the UN Sustainable Development Goals. The Disclosure rating includes seventeen UN SDGs including: 'Good Health & Wellbeing', 'Responsible Production & Consumption' and 'Life on Land'. The assessment of Organon Pharma Indonesia Tbk PT leverages intelligence from across the web and also from public documents by Organon Pharma Indonesia Tbk PT.
Organon Pharma Indonesia Tbk PT in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Organon Pharma Indonesia Tbk PT | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Organon Pharma Indonesia Tbk PT have an accelerator or VC vehicle to help deliver innovation?
Does Organon Pharma Indonesia Tbk PT disclose current and historical energy intensity?
Does Organon Pharma Indonesia Tbk PT report the average age of the workforce?
Does Organon Pharma Indonesia Tbk PT reference operational or capital allocation in relation to climate change?
Does Organon Pharma Indonesia Tbk PT disclose its ethnicity pay gap?
Does Organon Pharma Indonesia Tbk PT disclose cybersecurity risks?
Does Organon Pharma Indonesia Tbk PT offer flexible work?
Does Organon Pharma Indonesia Tbk PT have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Organon Pharma Indonesia Tbk PT disclose the number of employees in R&D functions?
Does Organon Pharma Indonesia Tbk PT conduct supply chain audits?
Does Organon Pharma Indonesia Tbk PT disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Organon Pharma Indonesia Tbk PT conduct 360 degree staff reviews?
Does Organon Pharma Indonesia Tbk PT disclose the individual responsible for D&I?
Does Organon Pharma Indonesia Tbk PT disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Organon Pharma Indonesia Tbk PT disclose current and / or historical scope 2 emissions?
Does Organon Pharma Indonesia Tbk PT disclose water use targets?
Does Organon Pharma Indonesia Tbk PT have careers partnerships with academic institutions?
Did Organon Pharma Indonesia Tbk PT have a product recall in the last two years?
Does Organon Pharma Indonesia Tbk PT disclose incidents of discrimination?
Does Organon Pharma Indonesia Tbk PT allow for Work Councils/Collective Agreements to be formed?
Has Organon Pharma Indonesia Tbk PT issued a profit warning in the past 24 months?
Does Organon Pharma Indonesia Tbk PT disclose parental leave metrics?
Does Organon Pharma Indonesia Tbk PT disclose climate scenario or pathway analysis?
Does Organon Pharma Indonesia Tbk PT disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Organon Pharma Indonesia Tbk PT disclose the pay ratio of women to men?
Does Organon Pharma Indonesia Tbk PT support suppliers with sustainability related research and development?
Does Organon Pharma Indonesia Tbk PT disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Organon Pharma Indonesia Tbk PT reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Organon Pharma Indonesia Tbk PT involved in embryonic stem cell research?
Does Organon Pharma Indonesia Tbk PT disclose GHG and Air Emissions intensity?
Does Organon Pharma Indonesia Tbk PT disclose its waste policy?
Does Organon Pharma Indonesia Tbk PT report according to TCFD requirements?
Does Organon Pharma Indonesia Tbk PT disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Organon Pharma Indonesia Tbk PT disclose energy use targets?
Does Organon Pharma Indonesia Tbk PT disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Organon Pharma Indonesia Tbk PT have a policy relating to cyber security?
Have a different question?
Potential Risks for Organon Pharma Indonesia Tbk PT
These potential risks are based on the size, segment and geographies of the company.